Keyphrases
Molecular Characterization
100%
Patient Outcomes
100%
Melanoma
100%
Nodal Metastasis
100%
Unknown Primary Site
100%
Melanoma of Unknown Primary Site
80%
Mutational Status
60%
Overall Survival
40%
5-year Survival
40%
Disease-free Survival
40%
Follow-up Time
20%
Molecular Features
20%
Molecular Targeted Therapy
20%
Mutually Exclusive
20%
NRAS mutation
20%
Multicentric
20%
Negative Impact
20%
Lymphadenectomy
20%
KIT mutation
20%
V600E
20%
BRAF mutation
20%
Coding Sequence
20%
Melanoma Patients
20%
Direct Sequencing
20%
BRAF Inhibitor (BRAFi)
20%
Groin
20%
Number of Metastatic Lymph Nodes
20%
Clinical Manifestations
20%
Medicine and Dentistry
Nodal Metastasis
100%
Cancer of Unknown Primary Origin
100%
Melanoma
100%
Overall Survival
37%
Disease Free Survival
37%
Motor Unit Potential
25%
Lymph Node Metastasis
12%
Retroperitoneal Lymph Node Dissection
12%
Molecularly Targeted Therapy
12%
Immunology and Microbiology
Overall Survival
100%
Disease Free Survival
100%
Motor Unit Potential
66%
Wild Type
33%
Lymph Node
33%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Disease Free Survival
100%
Motor Unit Potential
66%
Wild Type
33%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Cancer of Unknown Primary Site
100%
Overall Survival
37%
Disease Free Survival
37%
Lymph Node Metastasis
12%